Crizotinib

CD74 molecule ; Homo sapiens







18 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33000474 Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report. 2021 Mar 1
2 33945921 Crizotinib resistance conferred by BRAF V600E mutation in non-small cell lung cancer harboring an oncogenic ROS1 fusion. 2021 1
3 34319660 A case of lung adenocarcinoma with a novel CD74-ROS1 fusion variant identified by comprehensive genomic profiling that responded to crizotinib and entrectinib. 2021 Sep 1
4 34511132 Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study. 2021 Sep 13 1
5 34638496 Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL). 2021 Oct 7 1
6 32168429 Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants. 2020 May 2
7 32208297 A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab. 2020 May 1
8 33204104 A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma. 2020 3
9 31027745 Next-Generation Sequencer Analysis of Pulmonary Pleomorphic Carcinoma With a CD74-ROS1 Fusion Successfully Treated With Crizotinib. 2019 May 1
10 29343973 A patient with classic biphasic pulmonary blastoma harboring CD74-ROS1 fusion responds to crizotinib. 2018 2
11 29477381 CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib. 2018 May 28 3
12 29704675 Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-Small Cell Lung Cancer. 2018 Jul 1
13 26673800 A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer. 2016 May 15 3
14 25688157 Molecular Changes Associated with Acquired Resistance to Crizotinib in ROS1-Rearranged Non-Small Cell Lung Cancer. 2015 May 15 1
15 23724914 Acquired resistance to crizotinib from a mutation in CD74-ROS1. 2013 Jun 20 2
16 24047072 Acquired resistance to crizotinib from a mutation in CD74-ROS1. 2013 Sep 19 1
17 24047073 Acquired resistance to crizotinib from a mutation in CD74-ROS1. 2013 Sep 19 1
18 22215748 ROS1 rearrangements define a unique molecular class of lung cancers. 2012 Mar 10 1